Clinical Trial

Clinical Trial of Shugan Jieyu Capsule in Generalized Anxiety Disorder

Recruiting Phase 3
View on ClinicalTrials.gov →
Record status
This record was last updated December 18, 2024 (before its estimated February 28, 2025 completion). Its status may not reflect the trial's current state.
Summary
This is a randomized double-blind placebo-controlled phase 3 clinical trial to further validate the effectiveness and safety of Shugan Jieyu Capsules in treating generalized anxiety disorder.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2023-03-06.
Status change: Not Yet Recruiting → Recruiting 2024-12-17
Trial Details
NCT Number NCT05772104
Lead Sponsor Sichuan Jishengtang Pharmaceutical Co., Ltd.
Conditions Generalized Anxiety Disorder
Enrollment 495 participants
Start Date 2023-04-17
Primary Completion 2025-02-28 (estimated)
Study Completion 2025-06-01 (estimated)
Updated on ClinicalTrials.gov 2024-12-18